Back to the main directory
Company Analysis / Equity
- Novozymes Company Report by Morningstar
- 4Q Sell-Off and Shifting Mix Impacts AMG's AUM, Revenue, and Profitability; No Change to FVE by Morningstar
- Morningstar | 4Q Sell-Off and Shifting Mix Impacts AMG's AUM, Revenue, and Profitability; No Change to FVE by Morningstar
- Continental Benefits From Auto Industry Trends in Electronics, Emissions, and Safety by Morningstar
- Morningstar | Continental Benefits From Auto Industry Trends in Electronics, Emissions, and Safety by Morningstar
- Initiating Coverage of Kerry Group and Chr. Hansen With Wide Economic Moats; Kerry Is Our Top Pick by Morningstar
- Morningstar | Initiating Coverage of Kerry Group and Chr. Hansen With Wide Economic Moats; Kerry Is Our Top Pick. See Updated Analyst Note from 04 Feb 2019 by Morningstar
- Bill Gross' Departure Does Little to Alter Our Long-Term View of Janus Henderson; No Change to FVE by Morningstar
- Bill Gross' Departure Does Little to Alter Our Long-Term View of Janus Henderson; No Change to FVE by Morningstar
- Morningstar | Mortgages, Consumer Loans, and Business Financing Drive Solid 4Q Results for Santander Chile by Morningstar
- Morningstar | Bill Gross' Departure Does Little to Alter Our Long-Term View of Janus Henderson; No Change to FVE by Morningstar
- Morningstar | Sysco Delivers Solid Sales Growth and Modest Margin Gains in 2Q, but Shares Still Rich by Morningstar
- Weatherford Reports Solid Fourth Quarter Owing to Transformation Benefits by Morningstar
- Morningstar | Though Weaker Issuance Is a Short-Term Concern, Moody's Wide Moat Should Win Out in the Long Run by Morningstar
- Morningstar | Deutsche Celebrates First Full-Year Profit Since 2014 as It Hits Cost Saving Targets. See Updated Analyst Note from 04 Feb 2019 by Morningstar
- Morningstar | Deutsche Celebrates First Full-Year Profit Since 2014 as It Hits Cost Saving Targets. See Updated Analyst Note from 04 Feb 2019 by Morningstar
- Merck's Strong Immuno-Oncology and Vaccine Segments Drive Solid Growth by Morningstar
- Morningstar | Stifel Ends 2018 With Healthy Quarter; Management Becoming More Conservative With Capital by Morningstar
- Morningstar | Wide-Moat Clorox Cleans Up in 2Q With Sales and Profit Improvement, but Shares Rich by Morningstar
- Morningstar | Northrop Is Digesting Orbital ATK and Ramping Up Its Flagship B-21 Bomber and F-35 Programs by Morningstar
- Invesco's Purchase of OppenheimerFunds Should Help Offset Some Industry Headwinds by Morningstar
- Morningstar | Visa Is an Entrenched Tollbooth Business Enjoying a Long-Term Secular Tailwind by Morningstar
- Weaker Equity Performance and Outflows Affect Legg Mason's Fiscal 3Q; No Change to FVE by Morningstar
- Morningstar | Weaker Equity Performance and Outflows Affect Legg Mason's Fiscal 3Q; No Change to FVE by Morningstar
- C.H. Robinson's Growth Trajectory Will Moderate in 2019, but We Expect Continued Strong Execution by Morningstar
- Morningstar | Kerry's Unique Integrated Solutions Business Model Supports a Wide Moat by Morningstar
- PSA Technology: Update on Ferrotec – Still Semiconductor Driven by Pelham Smithers Associates Ltd
- Royal Set to Achieve 20/20 Vision One Year Early, Helped by Strong Demand and Operational Excellence by Morningstar
- Morningstar | Royal Set to Achieve 20/20 Vision One Year Early, Helped by Strong Demand and Operational Excellence by Morningstar
- Initiating Coverage of Kerry Group and Chr. Hansen With Wide Economic Moats; Kerry Is Our Top Pick by Morningstar
- Morningstar | Initiating Coverage of Kerry Group and Chr. Hansen With Wide Economic Moats; Kerry Is Our Top Pick by Morningstar
- Morningstar | Initiating Coverage of Kerry Group and Chr. Hansen With Wide Economic Moats; Kerry Is Our Top Pick by Morningstar
- Mortgages, Consumer Loans, and Business Financing Drive Solid 4Q Results for Santander Chile by Morningstar
- With a Successful Scottrade Integration Done, the Interest Rate Environment Is the Primary Concern by Morningstar
- Morningstar | Bill Gross' Departure Does Little to Alter Our Long-Term View of Janus Henderson; No Change to FVE by Morningstar
- Morningstar | With a Successful Scottrade Integration Done, the Interest Rate Environment Is the Primary Concern by Morningstar
- Ghosn Resigns as Renault CEO and Chairman; FVEs Unchanged--Renault EUR 88, Nissan JPY 1,480 by Morningstar
- Morningstar | Weatherford Reports Solid Fourth Quarter Owing to Transformation Benefits by Morningstar
- Deutsche Celebrates First Full-Year Profit Since 2014 as It Hits Cost Saving Targets by Morningstar
- Morningstar | Deutsche Celebrates First Full-Year Profit Since 2014 as It Hits Cost Saving Targets by Morningstar
- Morningstar | Deutsche Celebrates First Full-Year Profit Since 2014 as It Hits Cost Saving Targets by Morningstar
- Morningstar | Merck's Strong Immuno-Oncology and Vaccine Segments Drive Solid Growth by Morningstar
- Wide-Moat Clorox Cleans Up in 2Q With Sales and Profit Improvement, but Shares Rich by Morningstar
- Northrop Is Digesting Orbital ATK and Ramping Up Its Flagship B-21 Bomber and F-35 Programs by Morningstar
- Rising Profits Ahead Supported by Capacity Growth and Stringent Cost Controls at Carnival by Morningstar
- Morningstar | Invesco's Purchase of OppenheimerFunds Should Help Offset Some Industry Headwinds by Morningstar
- Despite Slowing Demand During 2H 2018, Fortune Brands Sets Solid Growth Targets in 2019 by Morningstar
- Morningstar | Despite Slowing Demand During 2H 2018, Fortune Brands Sets Solid Growth Targets in 2019 by Morningstar
- Analyst Ideas of the Week – Continued Backing from BHP’s Spin Off by Fundamental Research
- Morningstar | C.H. Robinson's Growth Trajectory Will Moderate in 2019, but We Expect Continued Strong Execution by Morningstar